These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2544239)

  • 21. Heparin/heparan sulfate interacting protein expression and functions in human breast cancer cells and normal breast epithelia.
    Jacobs AL; Julian J; Sahin AA; Carson DD
    Cancer Res; 1997 Nov; 57(22):5148-54. PubMed ID: 9371517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
    Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
    J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
    Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.
    Sekharam M; Nasir A; Kaiser HE; Coppola D
    Anticancer Res; 2003; 23(2B):1517-24. PubMed ID: 12820418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease.
    Peyrat JP; Bonneterre J; Laurent JC; Louchez MM; Amrani S; Leroy-Martin B; Vilain MO; Delobelle A; Demaille A
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1425-31. PubMed ID: 2972546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
    J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.
    Foekens JA; Portengen H; van Putten WL; Trapman AM; Reubi JC; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Dec; 49(24 Pt 1):7002-9. PubMed ID: 2555057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the calcitonin receptor by chemical cross-linking and photoaffinity labeling in human cancer cell lines.
    Moseley JM; Smith P; Martin TJ
    J Bone Miner Res; 1986 Jun; 1(3):293-7. PubMed ID: 2845728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 IGF receptor in human breast diseases.
    Peyrat JP; Bonneterre J
    Breast Cancer Res Treat; 1992; 22(1):59-67. PubMed ID: 1421425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-atom structural models for complexes of insulin-like growth factors IGF1 and IGF2 with their cognate receptor.
    Vashisth H; Abrams CF
    J Mol Biol; 2010 Jul; 400(3):645-58. PubMed ID: 20488191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue.
    Minuto F; Barreca A; Del Monte P; Cariola G; Torre GC; Giordano G
    J Clin Endocrinol Metab; 1989 Mar; 68(3):621-6. PubMed ID: 2537339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
    Foekens JA; Portengen H; Janssen M; Klijn JG
    Cancer; 1989 Jun; 63(11):2139-47. PubMed ID: 2541884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.
    Jammes H; Peyrat JP; Ban E; Vilain MO; Haour F; Djiane J; Bonneterre J
    Br J Cancer; 1992 Aug; 66(2):248-53. PubMed ID: 1323990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization and physiological development of receptors for insulin-like growth factors I and II (IGFs) in the mammary gland of ewes].
    Disenhaus C; Belair L; Djiane J
    Reprod Nutr Dev (1980); 1988; 28(2A):241-52. PubMed ID: 2967528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro.
    Minuto F; Del Monte P; Barreca A; Nicolin A; Giordano G
    Mol Cell Endocrinol; 1987 Dec; 54(2-3):179-84. PubMed ID: 2961640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of insulinlike growth factor I receptors in human colon cancer.
    Guo YS; Narayan S; Yallampalli C; Singh P
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1101-8. PubMed ID: 1312970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of two types of receptor for insulinlike growth factors in human colonic epithelium.
    Rouyer-Fessard C; Gammeltoft S; Laburthe M
    Gastroenterology; 1990 Mar; 98(3):703-7. PubMed ID: 2153600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer cell lines.
    Peyrat JP; Hondermark H; Louchez MM; Boilly B
    Cancer Commun; 1991; 3(10-11):323-9. PubMed ID: 1662060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.